Physician profile
Robert B Kevitch
NPI 1932188745
$982.91
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $116 · 2021: $306 · 2022: $334 · 2024: $23.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $329.94 | 2019-2022 | |
| Allergan, INC. | $149.63 | 2019-2022 | |
| Merz North America, INC. | $145.74 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $82.79 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $75.49 | 2020-2022 | |
| Galderma Laboratories, L.P. | $67.64 | 2020-2024 | |
| Incyte Corporation | $40.96 | 2022 | |
| Biofrontera INC. | $29.97 | 2022 | |
| Leo Pharma INC. | $18.46 | 2022 | |
| Abbvie INC. | $16.69 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.72 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $10.88 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kevitch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.